vs
Side-by-side financial comparison of Dexcom (DXCM) and UGI CORP (UGI). Click either name above to swap in a different company.
UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.6× Dexcom). Dexcom runs the higher net margin — 21.2% vs 14.4%, a 6.8% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.9%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -7.5%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.
DXCM vs UGI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.1B |
| Net Profit | $267.3M | $297.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 22.0% |
| Net Margin | 21.2% | 14.4% |
| Revenue YoY | 21.6% | 3.9% |
| Net Profit YoY | 153.6% | -20.8% |
| EPS (diluted) | $0.67 | $1.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.0B | $2.6B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.4B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $297.0M | ||
| Q3 25 | $283.8M | $-13.0M | ||
| Q2 25 | $179.8M | $-163.0M | ||
| Q1 25 | $105.4M | $479.0M | ||
| Q4 24 | $151.7M | $375.0M | ||
| Q3 24 | $134.6M | $-273.0M | ||
| Q2 24 | $143.5M | $-48.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 22.0% | ||
| Q3 25 | 20.1% | 1.1% | ||
| Q2 25 | 18.4% | -6.8% | ||
| Q1 25 | 12.9% | 26.6% | ||
| Q4 24 | 17.0% | 24.5% | ||
| Q3 24 | 15.3% | -20.4% | ||
| Q2 24 | 15.7% | 5.0% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 14.4% | ||
| Q3 25 | 23.5% | -1.1% | ||
| Q2 25 | 15.5% | -12.0% | ||
| Q1 25 | 10.2% | 18.2% | ||
| Q4 24 | 13.6% | 18.9% | ||
| Q3 24 | 13.5% | -22.6% | ||
| Q2 24 | 14.3% | -3.6% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.34 | ||
| Q3 25 | $0.70 | $-0.08 | ||
| Q2 25 | $0.45 | $-0.76 | ||
| Q1 25 | $0.27 | $2.19 | ||
| Q4 24 | $0.37 | $1.74 | ||
| Q3 24 | $0.34 | $-1.26 | ||
| Q2 24 | $0.35 | $-0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $251.0M |
| Total DebtLower is stronger | — | $6.0B |
| Stockholders' EquityBook value | $2.7B | $5.0B |
| Total Assets | $6.3B | $15.8B |
| Debt / EquityLower = less leverage | — | 1.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $251.0M | ||
| Q3 25 | $1.8B | $335.0M | ||
| Q2 25 | $1.2B | $350.0M | ||
| Q1 25 | $904.9M | $426.0M | ||
| Q4 24 | $606.1M | $240.0M | ||
| Q3 24 | $621.2M | $213.0M | ||
| Q2 24 | $939.2M | $183.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.0B | ||
| Q3 25 | — | $6.5B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.6B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.3B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $5.0B | ||
| Q3 25 | $2.7B | $4.8B | ||
| Q2 25 | $2.6B | $4.9B | ||
| Q1 25 | $2.3B | $5.0B | ||
| Q4 24 | $2.1B | $4.6B | ||
| Q3 24 | $2.0B | $4.3B | ||
| Q2 24 | $2.4B | $4.7B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $15.8B | ||
| Q3 25 | $7.5B | $15.5B | ||
| Q2 25 | $7.3B | $15.4B | ||
| Q1 25 | $6.8B | $15.7B | ||
| Q4 24 | $6.5B | $15.4B | ||
| Q3 24 | $6.4B | $15.1B | ||
| Q2 24 | $6.8B | $15.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 1.17× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $66.0M |
| Free Cash FlowOCF − Capex | — | $-155.0M |
| FCF MarginFCF / Revenue | — | -7.5% |
| Capex IntensityCapex / Revenue | — | 10.7% |
| Cash ConversionOCF / Net Profit | — | 0.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $282.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $66.0M | ||
| Q3 25 | $659.9M | $90.0M | ||
| Q2 25 | $303.0M | $289.0M | ||
| Q1 25 | $183.8M | $684.0M | ||
| Q4 24 | $301.4M | $164.0M | ||
| Q3 24 | $199.5M | $151.0M | ||
| Q2 24 | $279.4M | $390.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-155.0M | ||
| Q3 25 | $579.4M | $-168.0M | ||
| Q2 25 | $208.9M | $67.0M | ||
| Q1 25 | $96.8M | $538.0M | ||
| Q4 24 | $176.8M | $-47.0M | ||
| Q3 24 | $88.3M | $-115.0M | ||
| Q2 24 | $213.3M | $185.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -7.5% | ||
| Q3 25 | 47.9% | -14.4% | ||
| Q2 25 | 18.1% | 4.9% | ||
| Q1 25 | 9.3% | 20.4% | ||
| Q4 24 | 15.9% | -2.4% | ||
| Q3 24 | 8.9% | -9.5% | ||
| Q2 24 | 21.2% | 13.7% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 10.7% | ||
| Q3 25 | 6.7% | 22.1% | ||
| Q2 25 | 8.1% | 16.3% | ||
| Q1 25 | 8.4% | 5.5% | ||
| Q4 24 | 11.2% | 10.6% | ||
| Q3 24 | 11.2% | 22.0% | ||
| Q2 24 | 6.6% | 15.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.22× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 1.43× | ||
| Q4 24 | 1.99× | 0.44× | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
